Back to search

Article

MARS: Improved De Novo Peptide Candidate Selection for Non-Canonical Antigen Target Discovery in Cancer

2022-08-03

Abstract excerpt

<title>Abstract</title> <p>Cryptic Human Leukocyte Antigen (HLA)-presented peptide identification from unannotated genome sources is a priority for target antigen discovery for development of next generation immunotherapies in cancer. Current immunopeptidomic approaches utilize the integration of transcriptomics data to inform spectral interpretation, however, recent observations that tumour-associated antigen-en...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e5c5fd30-286a-5997-bb1f-4f95d76708cb
DOI
10.21203/rs.3.rs-1890352/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MARS: Improved De Novo Peptide Candidate Selection for Non-Canonical Antigen Target Discovery in CancerDOI 10.21203/rs.3.rs-1890352/v1
Select a neighboring publication to make it the new centre.